1 |
Plentz RR,Lankisch TO,Basturk M, et al. Prospective analysis of German patients with hepatocellular carcinoma undergoing trans-catheter arterial chemoembolization with or without prophylactic antibiotic therapy[J]. J Gastroenterol Hepatol, 2005, 20(7): 1134-1136.
|
2 |
Shelgikar CS,Loehle J,Scoggins CR, et al. Empiric antibiotics for transarterial embolization in hepatocellular carcinoma: indicat-ed?[J]. J Surg Res, 2009, 151(1): 121-124.
|
3 |
王宁,邱志宏.肝病患者围介入术期抗菌药物使用的必要性与特殊性[J].现代预防医学, 2012, 39(8): 2116-2117, 2120.
|
4 |
吴熙中,陈艳萍.抗生素在肝、肺癌血管内介入治疗中的应用[J].中国介入影像与治疗学, 2005, 2(2): 130-132.
|
5 |
刘纪营,马南,管生,等.预防性应用抗生素的不同方法对介入治疗并发肝脓肿的影响[J].介入放射学杂志, 2013, 22(6): 474-477.
|
6 |
Wang J,He XD,Zhang YC. Antibiotic prophylaxis in transarteri-al therapy of hepatocellular carcinoma: a meta-analysis[J]. Can J Gastroenterol, 2012, 26(2): 85-91.
|
7 |
Castells A,Bruix J,Ayuso C, et al. Transarterial embolization for hepatocellular carcinoma. Antibiotic prophylaxis and clinical meaning of postembolization fever[J]. J Hepatol, 1995, 22(4): 410-415.
|
8 |
王江云,陈勇,卢伟,等.原发性肝癌经动脉化疗栓塞预防性应用抗生素前瞻性研究[J].第一军医大学学报, 2005(6): 757-758.
|
9 |
高峰,张雪娜,陈茂振,等.原发性肝癌TACE术后预防性抗生素应用价值研究[J].介入放射学杂志, 2013, 22(2): 151-153.
|
10 |
邱晓玲,沈薇.血管内介入治疗围手术期预防性使用抗生素的临床意义[J].重庆医科大学学报, 2014(7): 1037-1040.
|
11 |
朱文艳,刘建勇,周永和,等.原发性肝癌介入治疗中抗生素的预防性应用探讨[J].山东医药, 2014(11): 59-61.
|
12 |
Chen C,Tsang YM,Hsueh PR, et al. Bacterial infections associat-ed with hepatic arteriography and transarterial embolization for hepatocellular carcinoma: a prospective study[J]. Clin Infect Dis, 1999, 29(1): 161-166.
|
13 |
Geschwind JF,Kaushik S,Ramsey DE, et al. Influence of a new prophylactic antibiotic therapy on the incidence of liver abscesses after chemoembolization treatment of liver tumors[J]. J Vasc In-terv Radiol, 2002, 13(11): 1163-1166.
|